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Introduction
Mutations that activate the Akt and Ras proto-oncogenes or the 
upstream insulin-like growth factor 1 (IGF-I) receptor are among 
the most frequently detected in human cancers (Rodriguez-
Viciana et al., 1994, 2005; Toker and Yoeli-Lerner, 2006). 
Because of their roles in stimulating cellular proliferation and 
inhibiting apoptosis, these oncogenes are widely believed to 
contribute to cancer by allowing damaged cells to survive, grow, 
and metastasize (DePinho, 2000; Pollak et al., 2004; Anisimov 
et al., 2005; Toker and Yoeli-Lerner, 2006). Mutations that cause 
the down-regulation of homologues of Ras, Akt, or IGF-I recep-
tors extend life spans in organisms ranging from yeast to mice 
(Longo and Finch, 2003), and deficiency in IGF-I or IGF-I–like 
signaling (IIS) is associated with decreased neoplastic death in 
mice (Vergara et al., 2004; Anisimov et al., 2005) or resistance 
to germline tumors in Caenorhabditis elegans (Pinkston et al., 
2006). In agreement with the widely accepted role for IGF-I, 
Akt, and Ras in cancer, Pinkston et al. (2006) proposed that the 
resistance of the C. elegans daf-2/insulin-receptor mutants to 
gld-1–dependent germline tumors is attributed to decreased cell 
division and increased apoptosis within the tumors. Although 
defects in cell division and apoptosis undoubtedly play a major 
role in mutagenesis and cancer, our previous studies in Saccharo­
myces cerevisiae provided evidence for a link between Sch9, 
homologue of mammalian S6K and Akt (Toda et al., 1988; 
Urban et al., 2007), and age-dependent spontaneous mutations 
in nondividing yeast cells (Fabrizio et al., 2004, 2005), which 
raises the possibility that proto-oncogene homologues may con-
tribute to DNA damage during aging independently of cell division 
(Lombard et al., 2005).
The present study investigates the mechanisms under-
lying the role of Sch9 in increasing DNA damage and genomic 
O
ncogenes contribute to tumorigenesis by pro-
moting growth and inhibiting apoptosis. Here 
we examine the function of Sch9, the Saccharo­
myces cerevisiae homologue of the mammalian Akt and 
S6  kinase,  in  DNA  damage  and  genomic  instability 
during aging in nondividing cells. Attenuation of age-
dependent increases in base substitutions, small DNA 
insertions/deletions, and gross chromosomal rearrange-
ments (GCRs) in sch9 mutants is associated with in-
creased mitochondrial superoxide dismutase (MnSOD) 
expression,  decreased  DNA  oxidation,  reduced REV1 
expression and translesion synthesis, and elevated resis-
tance to oxidative stress-induced mutagenesis. Deletion 
of REV1, the lack of components of the error-prone Pol, 
or the overexpression of SOD1 or SOD2 is sufficient to 
reduce age-dependent point mutations in SCH9 over-
expressors, but REV1 deficiency causes a major increase 
in GCRs. These results suggest that the proto-oncogene 
homologue Sch9 promotes the accumulation of superoxide-
dependent DNA damage in nondividing cells, which in-
duces  error-prone  DNA  repair  that  generates  point 
mutations to avoid GCRs and cell death during the first 
round of replication.
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We then extended the analysis to other types of DNA 
lesions by examining the occurrence of a specific single base-
substitution mutation (T to C: trp1­289 reversions, trp
 → Trp
+; 
Capizzi and Jameson, 1973) and small insertion/deletion mu-
tations (lys2­BglII → Lys
+); the latter may serve as an indica-
tor for nonhomologous end-joining activity (Heidenreich and 
Wintersberger, 1998; Heidenreich et al., 2003). Interestingly, 
SCH9-deficient cells displayed a twofold reduction of single 
point mutations (Fig. 1 E) as well as a fivefold reduction of the 
frequency  of  small  DNA  insertion/deletion  (Lys
+)  mutations 
compared with wild-type cells (Fig. 1 F). The results presented 
in Fig. 1 (A–F) suggest that the lack of SCH9 protects chrono-
logically aging yeast cells against a wide variety of mutations.
SCH9 deletion enhances G1 arrest and 
reduces age-dependent regrowth
The inability to properly exit the cell cycle can lead to senes-
cence and cancer (Campisi, 2001), and can contribute to muta-
genesis. Our previous studies and those from other laboratories 
suggest that life span–extending mutations cause a switch from 
a pro-growth to a pro-maintenance mode (Longo, 2003). To de-
termine whether the sch9 mutation increases protection against 
age-dependent genomic instability by promoting G1 arrest, we 
assessed cell cycle profiles and budding indices of wild-type 
and sch9 mutants. The deletion of SCH9 indeed reduced the 
budding index from 2–3% to 1% on days 3, 5, and 7 (Fig. 1 G). 
FACS analysis confirmed that sch9 cells (98% of the popula-
tion, starting from day 1) were arrested in the G1 phase (Figs. 1 H 
and S1 A). Notably, the low budding index as well as the high 
percentage of G1 arrested cells in sch9 cultures are in agree-
ment with our earlier work indicating that deletion of SCH9 
caused a major reduction in age-dependent “regrowth,” which 
appears to depend on adaptive mutations and resembles the dif-
ferentiation process that leads to tumorigenesis in mammalian 
cells (Fabrizio et al., 2003, 2004, 2005). The age-dependent 
early regrowth frequency (days 7–17; Madia et al., 2008) in a 
large number of cultures of three different genetic backgrounds 
confirmed that mutants lacking SCH9 were unable to regrow, 
whereas wild-type populations display the regrowth phenome-
non (Table S1).
Quiescent cells contribute to  
age-dependent mutagenesis
The inability of aging cells to properly arrest in G1 could lead to 
a higher mutation frequency (Bartkova et al., 2005; Houtgraaf 
et al., 2006; Burhans and Weinberger, 2007; Löbrich and Jeggo, 
2007). Sch9 may increase mutations during chronological aging 
by promoting replication and cell division before the cell is able 
to repair DNA damage, causing “replication stress” (Weinberger 
et al., 2007). To test this possibility, we isolated quiescent and 
nonquiescent cells from cultures aging chronologically using the 
Percoll density gradient fractionation (Fig. 2 A; Allen et al., 2006; 
Aragon et al., 2008; Madia et al., 2008). This method allowed the 
separation of two distinct subpopulations: the upper fraction, 
mainly composed of a heterogeneous population of nonquiescent 
cells, including dividing mother cells, nondividing, apoptotic, 
and necrotic cells; and a lower fraction mainly composed of 
instability. We present data indicating that, in chronologically 
aging yeast, DNA damage occurs primarily in quiescent cells. 
The deletion of the proto-oncogene homologue SCH9 postpones/
attenuates age-dependent mutagenesis by up-regulating the   
transcription factor Gis1, increasing the expression of mitochon-
drial SOD2, preventing superoxide-dependent DNA oxidation, 
and reducing the expression of REV1and translesion synthe-
sis (TLS) activity. We propose that both superoxide and the 
error-prone Rev1/Pol-dependent TLS are required for the major 
portion of age-dependent mutations.
Results
Sch9 promotes age-dependent  
genomic instability
The yeast chronological life span (Fabrizio and Longo, 2003, 
2007) has provided a paradigm for the identification of key 
pathways  responsible  for  the  regulation  of  life  span  and   
age-dependent damage (Fabrizio et al., 2001). The combina-
tion of this simple model organism with several mutator as-
says (Madia et al., 2007) has proven to be a valuable system 
to  address  the  mechanisms  underlying  age-dependent  ge-
nomic instability.
Using the canavanine resistance assay (Can
r), which de-
tects mutations that abolish CAN1 function (Chen and Kolodner, 
1999), we have previously reported that chronologically aging 
yeast displayed a progressive increase of spontaneous mutation 
frequency (Fabrizio et al., 2004). More recently, we demonstrated 
that this age-dependent increase of genomic instability encom-
passed various categories of mutations: gross chromosomal 
rearrangements (GCRs; Can
r5FOA
r), point mutations (trp1­289 
reversions, trp
 → Trp
+) and small insertion/deletion muta-
tions (lys2­BglII → Lys
+; Madia et al., 2008). The deletion of 
SCH9 not only extends life span (Fig. 1 A) but also attenuates/
delays the age-dependent increase in spontaneous Can
r mutation 
frequency (Fig. 1 B; Fabrizio et al., 2004, 2005) and prevents 
the premature genomic instability caused by the Sgs1 helicase 
deficiency (Madia et al., 2008).
Given the homology to the mammalian AKT and S6K 
and their implication in tumorigenesis, we investigated the 
role of Sch9 in the regulation of genomic instability and the 
mechanism linking its activity to DNA mutations. We deter-
mined the cumulative number of Can
r mutations from day 1 to 
day 7 in the wild type and to day 15 in sch9 cells, which rep-
resent the 50% survival point of each population, respec-
tively (Fig. 1 C). The data indicated that in SCH9-deficient 
cells, the protection against the generation of age-dependent 
mutations was not simply the result of postponed mortality (P = 
0.0013, cumulative Can
r mutations in the wild type on day 7 
vs. sch9 on day 15; Fig. 1 C). Consistent with the observed 
low amount of Can
r mutations (Fig. 1 B), the deletion of SCH9 
caused a significant reduction (10-fold compared with wild-
type cells) in GCRs over the 13-d period of a chronological 
life span study (Fig. 1 D). Notably, only 1% of the wild-type 
cells survived to day 13 (Fig. 1 A), which indicates that GCRs 
are very high in the small subpopulation of old cells that sur-
vived to advanced ages.511 SUPEROXIDE AND REV1 MEDIATE SCH9-DEPENDENT MUTATIONS • Madia et al.
did not occur during aging but during multiple rounds of cell 
division after exit from G0, we would expect the additional 
population doubling of the 2 × 10
7 cells to cause a major in-
crease in mutation frequency. The frequency of mutations nor-
malized for population size, instead, remained the same for 
cells  exposed  to  canavanine  before  or  after  one  population 
doubling (Fig. 2 F), which suggests that at least the initial DNA 
damage in the CAN1 gene occurs in the nondividing cells.
Gis1, a stress-response transcription 
factor downstream of Sch9, regulates the 
expression of REV1 and DNA mutations
The anti-aging and stress-resistance effects of the sch9 muta-
tions depend on the protein kinase Rim15 and its downstream 
stress response transcription factors Gis1, Msn2, and Msn4 
(Fabrizio et al., 2001, 2003; Wei et al., 2008). Deficiency in 
Gis1 led to an elevation of mutation frequency in the wild type 
(Fig. 3 B) and reversed the protective effect of sch9 on age-
dependent mutations starting from day 9 (Fig. 3, A and B). 
To investigate further the mediators of the Sch9 effect on DNA 
mutations, we obtained the global gene expression profiles of 
2.5-d-old sch9 and wild-type cells. Among the DNA repair 
genes, REV1, encoding the deoxycytidyl transferase that is in-
volved in TLS and the repair of abasic sites, and the recombi-
nation repair genes RAD51 and RAD54 were among the most 
down-regulated (Fig. 3 C and Table S2) in the long-lived 
sch9 mutants.
REV1 mRNA level was 40% lower in sch9 mutant cells 
compared with wild-type cells on day 3 (Fig. 4 A). Deletion of 
quiescent cells (Fig. 2, A and B; and Fig. S1 B; Allen et al., 2006; 
Aragon et al., 2008). The budding indices were also measured in 
both the quiescent and nonquiescent cell fraction (Fig. 2 D).
On day 3, 60% of wild-type cells were in the upper non-
quiescent fraction (Fig. 2 C). This fraction increased gradually 
from day 3 to day 7. Interestingly, the Can
r mutation frequency 
in the nonquiescent wild-type subpopulation was significantly 
lower than that in the quiescent subpopulation (Fig. 2 E). Further-
more, the frequency of mutations in the nonquiescent subpopula-
tion remained unchanged over time, whereas an age-dependent 
increase of mutations was observed in the quiescent fraction 
(P < 0.05: day 7 vs. day 3; Fig. 2 E). This result indicates that 
quiescent cells may accumulate DNA damage that leads to mu-
tations. In contrast to the wild type, SCH9-deficient cells were 
mostly quiescent, as indicated by FACS analysis (Figs. 1 H and 
S1 B). From day 3 to day 7, >90% of the SCH9-deficient cells 
separated in the lower fraction compared with 10–40% of wild-
type cells (Fig. 2 C). The deletion of SCH9 caused a decrease of 
mutation frequency in the quiescent fraction compared with that 
of wild type, and abolished the age-dependent increase in muta-
tions (Fig. 2 E). The latter data suggest that the effect of SCH9 
deletion on the cell cycle state does not play a major role in age-
dependent mutations.
To test whether mutations may occur during the multiple 
rounds of cell divisions required to generate a colony and not 
during either the aging of the nondividing population or the 
very first round of replication, we allowed old wild-type and 
sch9 cells to undergo one population doubling before treat-
ment with the toxic l-canavanine sulfate. If the DNA damage 
Figure  1.  Attenuated  age-dependent  genomic  insta-
bility in cells lacking the oncogene homologue SCH9.  
(A) Chronological survival. Data represent the mean ± 
SEM (error bars), n = 12–14. (B) Mutation frequency over 
time in the CAN1 gene (measured as Can
r mutants/10
6 
cells, n = 20). (C) Cumulative mutation frequency, mea-
sured as Can
r mutants/10
6 cells, calculated from day 1 
to day 7 or to day 15 in the wild type (DBY746) and 
mutants lacking SCH9. Day 7 and day 15 represent 
the 50% survival point of the wild type and sch9 
population, respectively. n = 20. **, P < 0.01; ***, P < 
0.001; ANOVA test, Tukey’s test versus wild type (WT) 
on day 7. (D) GCR frequency (Can
r5FOA
r mutants/10
8 
cells, n = 10–11). (E) Age-dependent base substitutions 
(trp1-289  reversion)  frequency  (n  =  8–9).  (F)  Small 
DNA insertion/deletion mutations in the lysBglII back-
ground (EH150 strains, n = 8–9). (G) Budding index of 
chronologically aging cells (n = 6). (H) Cell cycle pro-
file (FACS) during chronological aging. Strains shown 
are wild type (DBY746) and sch9. Data represent the 
mean ± SEM (error bars). *, P < 0.05; **, P < 0.01; 
***, P < 0.001; two-tailed t test, sch9 versus WT at 
the indicated time points.JCB • VOLUME 186 • NUMBER 4 • 2009   512
in sch9 mutants might be partially responsible for the effect 
on life span and mutations (Fig. 3, A and B).
The Y superfamily DNA polymerase 
Rev1 and Pol mediate Sch9-dependent 
mutations during aging
To gain further insight into the types of age-dependent muta-
tions, we analyzed the mutation spectra in Can
r mutant colonies 
arising from chronologically aging wild-type and sch9 cultures 
GIS1 in both wild-type and sch9 mutant cells was associated 
with significant increase in the REV1 mRNA level (Fig. 4 A), 
suggesting that Sch9 modulates Rev1 expression/activity par-
tially through the down-regulation of the transcription factor 
Gis1. However, the deletion of SCH9 caused a major reduc-
tion of REV1 expression and of mutation frequency during the 
first 7 d of survival even in GIS1-deficient cells, which sug-
gests that part of the protective effect is Gis1 independent. 
Other transcription factors such as Msn2 and Msn4 activated 
Figure 2.  Genomic instability arises from quies-
cent cells during chronological aging. (A) Density- 
gradient separation of nonquiescent (upper) and   
quiescent (lower) cells from chronologically aging 
cultures. (B) Calcofluor staining of upper and 
lower fractions from wild-type and sch9 mu-
tant cultures. The arrows indicate budding cells. 
Bar, 10 µm. (C) Percentage of upper and lower 
fractions in the culture. (D) Budding indices of   
upper and lower fractions (n = 6–7). (E) Mutation 
frequency in CAN1 gene (Can
r mutants/10
6 
cells) in the upper and lower fractions (n = 6–7).   
(F) Mutation frequency in the CAN1 gene be-
fore and after allowing the cells to undergo one 
population doubling during a standard chrono-
logical life span study (n = 4). Error bars indi-
cate ±SEM. (C–E) Data represent the mean ± SEM   
(error bars); *, P < 0.05; **, P < 0.01; two-tailed 
t test, sch9 versus wild type (WT). ^, P < 0.05; 
^^, P < 0.01; two-tailed t test, day 5 or day 7 
versus day 3 of the same strain.513 SUPEROXIDE AND REV1 MEDIATE SCH9-DEPENDENT MUTATIONS • Madia et al.
Considering that REV1 was among the most down-regulated 
DNA repair-related genes in sch9 (Fig. 3 C and Table S2) and 
that its mRNA expression was significantly increased in the 
absence of the downstream Sch9 effector Gis1 (Fig. 4 A), we 
tested whether the Rev1 protein mediated the effect of Sch9 on 
age-dependent genomic instability. In the DBY746 background, 
spontaneous age-dependent mutation frequency started at a much 
lower level and did not increase in cells lacking REV1 (Fig. 4 C). 
Similar results were obtained in the BY4741 background (Fig. 4, 
B and C). rev1 cells died earlier than wild-type cells in the 
DBY746 (Fig. 4 B) but not in the BY4741 genetic background 
(Fig. 4 B), indicating that its role in the repair of double strand 
breaks and other lesions could be important for survival. In agree-
ment with the role of Rev1 in mediating the Sch9-dependent mu-
tagenesis, the deletion of both SCH9 and REV1 did not further 
decrease the age-dependent mutation frequency (Fig. 4 C). In 
contrast, overexpression of SCH9, which models mammalian 
oncogenic mutations, caused a doubling of the frequency of age-
dependent mutations (Fig. 4 E). The deletion of REV1 reversed 
the hypermutagenic phenotype of mutants overexpressing SCH9, 
although it also led to early death (Fig. 4, D and E).
REV1  overexpression  increased  Can
r  mutation  frequency 
(Fig. 4 E), and overexpression of REV1 in sch9 mutants reversed 
the protective effect of this longevity mutation only on day 9 and 
day 11, indicating that sch9 exerts additional protection indepen-
dently of Rev1 (Fig. 4 E). Interestingly, larger lesions such as GCRs 
occurred more frequently in cells lacking REV1 (10–25-fold 
higher than in wild-type cells; Fig. 4 G), which suggests that, dur-
ing aging, the Rev1 protein contributes to the generation of point 
mutations as part of an emergency response aimed at preventing 
DNA rearrangements and deletions, which could be lethal.
Pol consists of a catalytic subunit Rev3 and an accessory 
Rev7, which associates with Rev1 and is involved mainly in DNA 
lesion bypass (Gan et al., 2008). To test whether the Pol was also 
responsible for an increase in age-dependent mutations, we stud-
ied mutants lacking either REV3 or REV7. Cells deficient of Rev3 
or Rev7 lived shorter than wild-type cells (Fig. 5, A and C). In 
both DBY746 and BY4741 genetic backgrounds, Rev3-deficient 
on day 7, when the difference in mutation frequency was elevated 
and 50% of the wild-type population was still alive (Fig. 1 C 
and Table I). Sequencing data of Can
r mutants from wild-type 
cultures indicated a high occurrence of multiple mutations within 
a short stretch of a 500–1,000-bps DNA sequence (6 out of 10 
mutated  CAN1  genes):  base  substitutions  accompanied  with 
frameshift mutations caused by small deletion or insertion of 
homopolymeric runs (sequences of 3–4 or more identical nucle-
otides, often As and/or Ts; Table I). In agreement with the age-
dependent increase in oxidative stress (Moraes et al., 1990; 
Kreutzer and Essigmann, 1998; Wang et al., 1998), we observed 
a high occurrence of G → T (transversion) or C → T (transition) 
mutations in wild-type cells, which was not seen in the sch9 
cells (Table I). It is not clear why 5 out of 10 sequenced CAN1 
genes from sch9 mutant colonies contained a C → A base sub-
stitution at position 11 away from ATG (Table I). One possibil-
ity is that this base may constitute a mutation hot spot. Another 
possibility  is  that  the  mutation  generated  during  the  growth 
phase expanded with the population. Multiple mutational events 
were not observed in cells lacking SCH9. Only 2 out of 10 Can
r 
mutants from sch9 cultures contained multiple substitution/
deletion/insertion mutations on day 7 (Table I).
The  mutation  pattern  observed  in  wild-type  cells  was 
consistent with the recruitment to the DNA lesion site of   
error-prone polymerases, which is analogous to SOS-induced 
mutagenesis in Escherichia coli mediated by PolIV and PolV of 
the Y superfamily of polymerases (Tang et al., 2000; Kobayashi 
et al., 2002). This family includes Rev1 and Rad30 (Pol) in 
S. cerevisiae (Ohmori et al., 2001). Most spontaneous and 
damage-induced mutagenesis during growth phase was found 
to depend on Rev1 and the DNA polymerase zeta (Pol, which 
belongs to the B superfamily of DNA polymerases; Quah et al., 
1980). Sloppy DNA synthesis by error-prone polymerases could 
then have been responsible for the multiple mutations observed 
in the aging wild-type cells (Table I). The absence of multiple 
mutation events in the CAN1 gene in 7-d-old rev1 mutants 
(Table I) suggests a role for Rev1 in the sloppy DNA synthesis 
leading to the secondary mutations.
Figure 3.  Stress response transcription factor Gis1   
is  required  for  life  span  extension  and  attenuated 
genomic instability associated with SCH9 deficiency. 
(A) Chronological survival (n = 11) and (B) mutation 
frequency in the CAN1 gene (n = 11) of the wild 
type (WT; DBY746) and sch9 mutants. ^, P < 0.05; 
^^, P < 0.01; two-tailed t test, sch9 gis1 versus 
sch9 at the indicated time points. (C) mRNA levels 
of REV1, REV3, REV7, and recombination genes in-
volved in DNA repair. WT (DBY746) and sch9 were 
grown in SDC media. Cells were collected on day 
2.5  for  mRNA  extraction  and  microarray  analysis. 
Data represent mean ± SEM (error bars) of percent-
age change, sch9 versus WT (n = 3). For complete 
microarray data, see Table S2.JCB • VOLUME 186 • NUMBER 4 • 2009   514
ciency in Rad30 (Pol), which is mainly involved in the error-free 
DNA damage bypass (Johnson et al., 1999; Washington et al., 
1999; Prakash et al., 2000), caused an elevated age-dependent 
increase of mutation frequency (Fig. 5 D). These data strongly 
cells showed a reduction of age-dependent Can
r mutations similar 
to that observed in the rev1 mutants (Fig. 5, B and D; and Fig. 4 C). 
In the BY4741 background, Rev7 deficiency also caused a major 
reduction in mutation during aging (Fig. 5 B). However, defi-
Figure 4.  The age-dependent increase in genomic instability is   
mediated by Rev1. (A) mRNA levels of REV1 in wild-type (WT; DBY746),   
sch9, gis1, and gis1 sch9 cells. mRNA extracted from 3-d-old 
cells were subjected to quantitative real-time PCR analysis. **, P < 
0.01, mutant versus WT; ^^, P < 0.01, mutant versus sch9, n = 12, 
ANOVA test, Tukey’s test. (B) Chronological survival and (C) muta-
tion frequency over time in the CAN1 gene of wild type, sch9, 
rev1, and rev1D sch9 in both the DBY746 and BY4741 genetic 
backgrounds. ***, P < 0.001; rev1 versus WT. ^, P < 0.05; 
rev1 sch9 versus sch9, two-tailed t test at indicated time points 
(n = 9). (D) Chronological survival and (E) mutation frequency over 
time in the CAN1 gene of wild-type, sch9, rev1, and cells over-
expressing SCH9 or REV1. *, P < 0.05; **, P < 0.01; ***, P < 
0.001; mutant versus WT. ^, P < 0.05; ^^, P < 0.01; sch9 REV1ox 
versus sch9. a, P < 0.05; rev1SCH9ox versus SCH9ox, two-
tailed t test at indicated time points (n = 6–9). (F) Chronological sur-
vival and (G) GCRs in the wild type and rev1 mutants. **, P < 
0.01; ***, P < 0.001; rev1 versus WT, two-tailed t test at indi-
cated time points (n = 4). Error bars indicate ±SEM.515 SUPEROXIDE AND REV1 MEDIATE SCH9-DEPENDENT MUTATIONS • Madia et al.
observed in the wild-type extract when used at 5, 10, or 20 µg, 
which is in agreement with the lesion bypass efficiency observed   
in vivo (Pagès et al., 2008). Furthermore, in the nuclear extract 
from the wild type, 20–25% of all extended products represented 
the incorporation opposite the abasic site, whereas <5% incorpora-
tion opposite the lesion was observed in sch9 (Fig. 5 E).
SCH9 deletion protects against  
DNA oxidation
The Rev1/Pol-dependent TLS is activated in response to DNA 
damage. Thus, we asked whether SCH9 deficiency might also 
suggest that the error-prone Rev1–Pol complex plays a central 
role in the generation of point mutations and small insertions/
deletions, but prevents GCRs during chronological aging.
To test further the hypothesis that error-prone polymerases 
mediate age-dependent mutations, we investigated the TLS in   
3-d-old wild-type and sch9 mutant cultures. Nuclear extracts from 
both wild-type and sch9 mutant cells were capable of extending 
the 
32P-labeled primer on undamaged DNA templates (Fig. 5 E). In 
contrast to wild-type cells, nuclear extracts from sch9 mutants 
were deficient in lesion bypass activity on the DNA templates con-
taining an abasic site (Fig. 5 E). About 5% TLS efficiency was 
Table I.  Mutations spectra observed in Can
r mutant colonies from 7-d-old wild-type, sch9, and rev1 cultures
Strains Clone Type Base change Mutations Position from ATG Sequence
WT
a 1 Base substitution C → T Proline-leucine 656 5-TGTTCCCTGTC-3
WT
a 2 Base substitution C → T Proline-serine 937 5-GCTGCAAACCCC-3
WT
a 3 Base substitution T → G Asparagine-lysine 1,173 5-AAATTCAAATA-3
WT
a 3 Insertion G Frameshift 1,710 5-GAGGCGAATT-3
WT
a 4 Base substitution G → C Alanine-proline 709 5-TTTTAGCCATTA-3
WT
a 4 Deletion TG Frameshift 1,098–1,099 5-TTGCTATTGAGA-3
WT
a 5 Base substitution G → T Glycine-valine 353 5-ACGCCGGCCCA-3
WT
a 5 Insertion A Frameshift 1,341 5-CAAAAGTTTTC-3
WT
a 6 Deletion AT Frameshift 1,129–1,130 5-GTCACATATCTT-3
WT
a 6 Insertion T Frameshift (T3-T4) 1,086 5-CCTTTTATTATT-3
WT
a 7 Base substitution G → T Tryptophan-cysteine 531 5-GTTTTCTTGGCA-3
WT
a 7 Deletion A Frame-shift (A3-A2) 663 5-AAATATTACGGT-3
WT
a 7 Insertion T Frameshift (T3-T4) 1,086 5-CCTTTTATTATT-3
WT
a 8 Base substitution G → A Glutamic A–lysine 679 5-AATTCGAGTTCT-3
WT
a 8 Base substitution G → T Valine-phenylalanine 907 5-AACTATTTGGTA-3
WT
a 8 Deletion A Frameshift 1,217 5-ATCAAAGAACAC-3
WT
a 9 Duplication NA 248 bp 184–431 NA
WT
a 10 No PCR NA NA NA NA
sch9 1 Base substitution C → A Serine-STOP 11 5-AAATTCAAAAG-3
sch9 2 Base substitution C → A Serine-STOP 11 5-AAATTCAAAAG-3
sch9 3 Base substitution C → A Serine-STOP 11 5-AAATTCAAAAG-3
sch9 4 Base substitution C → A Serine-STOP 11 5-AAATTCAAAAG-3
sch9 5 Base substitution C → A Serine-STOP 1,244 5-CTGTCAAGGAC-3
sch9 6 Base substitution T → C Phenylalanine-leucine 682 5-ATTCGAGTTCT-3
sch9 7 Insertion T Frameshift (T6-T7) 1,386 5-CTTTTTTTGCAT-3
sch9 8 Base substitution T → G Isoleucine-serine 305 5-GGTACTATTGGT-3
sch9 8 Insertion T Frameshift 1,013 5-TATTATTTCATT-3
sch9 9 Base substitution C → A Serine-STOP 11 5-AAATTCAAAAG-3
sch9 9 Base substitution C → A No change 1,347 5-TTTTCGAATGG-3
sch9 10 Insertion T Frameshift (T4-T5) 1,022 5-GGACTTTTTAGT-3
sch9 10 Insertion T Frameshift (T6-T7) 1,386 5-CTTTTTTTGCAT-3
rev1 1 Base substitution C → T Arginine-serine 1,195 5-GGTTCCCGTAT-3
rev1 2 Insertion A Frameshift (A3-A4) 702 5-CAAAAGTTTA-3
rev1 3 Deletion G Frameshift 422 5-GGGTGAAATGG-3
rev1 3 Deletion AAA A3-A0 425-427 5-GGGTGAAATGG-3
rev1 4 Deletion G Frameshift 422 5-GGGTGAAATGG-3
rev1 4 Deletion AAA A3-A0 425-427 5-GGGTGAAATGG-3
rev1 5 No PCR NA NA NA NA
rev1 6 Base substitution G → A Tryptophan-STOP 522 5-GTATTGGTTTTC-3
rev1 7 Base substitution C → T Serine-leucine 1,214 5-TATCAAAGAAC-3
rev1 8 Base substitution C → T Histidine-tyrosine 274 5-CAAAGACATATT-3
Letters in bold indicate base substitutions; bold and italics indicate insertions; underline indicates deletions. NA, not applicable.
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opposite of 8-OHdG, thus leading to a G → T transversion (Prakash 
et al., 2005), which is one of the most common mutations found 
in chronologically aging cells (Table I).
Increased protection against oxidation-  
but not alkylation-dependent DNA  
damage in sch9 mutants
To test whether the lack of SCH9 decreased age-dependent ge-
nomic instability by improving DNA repair, we monitored the 
mutagenesis induced by either oxidation (hydrogen peroxide 
[H2O2]) or alkylation (methyl methane sulfonate [MMS]) in non-
dividing cells. Survival, Can
r, and GCRs frequencies in 3-d-old 
wild-type and sch9 cells were determined after exposure to 
100 mM H2O2 for 30 min or to 0.02% of MMS for 50 min. After 
treatment, cells were washed four times and allowed to repair 
DNA without dividing in toxin-free expired synthetic dextrose 
complete (SDC) medium obtained from parallel aging cultures. 
Can
r mutations and GCRs were measured 30 min, 2 h, and 5 h 
after the end of each treatment. The exposure to hydrogen per-
oxide had little or no effect on sch9 viability (10% cell death), but 
protect against oxidative damage to DNA. Cells were treated with 
1 mM H2O2 on days 1 and 3, and Can1 mutation frequency was 
monitored for 13 d. In the wild-type strain (DBY746), the initial 
oxidative treatment led to a fourfold increase in Can
r mutations, 
which continued to increase until day 9, when the great majority 
of cells were dead (Fig. 6, A and B). In H2O2-treated sch9 cells, 
mutation frequency and viability, instead, were unaffected or 
slightly lower, respectively, suggesting that the SCH9 deletion pro-
tects cells against oxidation-induced DNA damage/mutagenesis 
and cell death (Fig. 6, A and B). Indeed, a sixfold increase of the 
8-hydroxy-2  deoxyguanidine  (8-OHdG)  level  was  observed 
when comparing day 1 versus day 7 in wild-type cells, whereas 
Sch9-deficient cells showed significantly lower age-dependent 
accumulation of 8-OHdG (Fig. 6 C). Furthermore, sch9 mutant 
cells were protected from oxidative damage (Fig. 6 D), which is 
in agreement with the lack of Can
r mutation frequency increase 
during chronological aging (Fig. 6 B). In vivo, 8-OHdG is a prev-
alent oxidative lesion that, when unrepaired, can lead to G-to-T 
transversion (Grollman and Moriya, 1993; Moriya, 1993; Le Page 
et al., 1995). Pol incorporates A (fives times more likely than C) 
Figure  5.  TLS  mediates  the  age-dependent 
increase in genomic instability. (A) Chronologi-
cal survival and (B) mutation frequency (Can
r) 
of the wild type (BY4741) and mutants defi-
cient of Pol, rev3, and rev7. *, P < 0.05; 
**, P < 0.01; mutants versus wild type (WT) 
two-tailed  t  test  at  the  indicated  time  points   
(n  =  4).  (C)  Chronological  survival  and   
(D) mutation frequency (Can
r) of the wild type 
(DBY746), rev3, and rad30 mutants. *, P < 
0.05; **, P < 0.01; ***, P < 0.001; mutants 
versus  WT,  two-tailed  t  test  at  the  indicated 
time  points  (n  =  6–10).  Error  bars  indicate 
±SEM.  (E)  Abolished  TLS  in  Sch9-deficient 
cells. Nuclear extracts from 3-d-old stationary 
phase wild-type (DBY746) and sch9 mutant 
cells were incubated with undamaged or aba-
sic site-containing DNA templates for 30 min 
at 30°C. Primer extension products were ana-
lyzed on 19% polyacrylamide gels. There was 
no lesion bypass observed in sch9 mutants. 
Free primers are indicated by the arrow. TLS 
products are indicated by solid (undamaged) 
or broken (damaged) lines. On the right, the 
percentage of incorporation opposite the aba-
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gave a small amount of protection against mutations and GCRs 
in response to MMS (Fig. 6, I and J). These results indicate that 
sch9 mutant cells are not well protected from alkylating DNA 
damage but are partially protected from alkylation-induced point 
mutations and small insertions/deletions (Fig. 6 I).
The role of superoxide in  
age-dependent mutations
Based on the age-dependent increase of 8-OHdG levels (Fig. 6 C), 
the spectra of Can
r mutations (Table I), the involvement of the 
killed 90% of the wild-type cells (Fig. 6 E). 2 h after treatment 
with H2O2, Can
r mutation frequency in sch9 showed only a minor 
increase and remained sixfold lower than that of wild-type cells 
(Fig. 6 F). Similarly, the sch9 mutant did not show any increase 
in GCRs frequency in contrast to the wild type, which displayed 
a >100-fold increase in GCRs by 5 h (Fig. 6 G).
In contrast to its role in protecting against oxidative stress-
induced mutations, the sch9 mutation did not protect against 
alkylation-induced DNA damage (Fig. 6, H, I and J). Wild-type 
cells were slightly more sensitive to 0.02% MMS, and sch9 only 
Figure 6.  The lack of SCH9 protects against oxidative stress-induced genomic instability. (A) Chronological survival and (B) mutation frequency (Can
r) of 
the wild type (DBY476) and sch9 mutants. Cells were treated with 1 mM H2O2 at day 1 and day 3. *, P < 0.05; **, P < 0.01; sch9 versus wild type 
(WT), two-tailed t test at the indicated time points (n = 4). (C) 8-OHdG contents in the wild type (DBY746) and sch9 mutants during chronological aging. 
(D) Day 3 SDC wild-type and sch9 cultures were treated with 1 mM H2O2 for 48 h.The mean of two independent experiments in duplicate is presented. 
(E–G) Wild-type (DBY746) and sch9 mutant cells were exposed to 100 mM H2O2 for 30 min. Survival (E), mutation frequency (F; Can
r), and GCR   
(G; Can
r5FOA
r) were monitored at 30 min, 2 h, and 5 h after the end of H2O2 treatment. (H–J) Wild-type (DBY746) and sch9 mutant cells were exposed 
to 0.02% MMS for 50 min. Error bars indicate ±SEM. Survival (H), mutation frequency (I; Can
r), and GCR (J; Can
r5FOA
r) were monitored at 30 min and 
5 h after the end of MMS treatment. For E–J, data represent mean ± SEM (error bars), n = 3. *, P < 0.05; **, P < 0.01; two-tailed t test at the indicated 
time points, sch9 versus WT.JCB • VOLUME 186 • NUMBER 4 • 2009   518
Discussion
Age-dependent DNA damage and cancer are widely believed to 
depend on mutations associated with the number of divisions 
completed by a cell. Here, in the study of a unicellular eukaryote, 
the frequencies of Can
r mutations and GCRs (Fig.1 B and D) 
reached 3- and 20-fold, respectively, higher levels in cells aging 
under nondividing conditions than in the population resulting 
from the many divisions necessary for the expansion from the 
initial 100 thousand to 1 billion cells contained in each aging 
study (we refer to the Can
r and GCRs frequencies reached in the 
cell population at the end of the growth phase on day 1).
Mutated Ras, Akt, and PTEN are widely believed to con-
tribute to cancer by promoting growth and preventing apoptosis 
(Pollak et al., 2004). Based on mammalian studies, inhibition 
of Ras and Akt is predicted to slow down growth and promote 
the apoptosis of cancer cells. Studies by our laboratory and others 
have shown that yeast homologues of mammalian Ras and 
Akt/S6K promote aging, oxidative stress, and age-dependent mu-
tations (Fabrizio et al., 2001, 2003, 2004; Hlavatá and Nyström, 
2003). Although Sch9 and Ras promote growth in S. cerevisiae, 
we show that Sch9 can promote DNA damage during aging in 
nondividing cells. Interestingly, the separation of aging wild-type 
cultures by a density gradient revealed that quiescent cells, other-
wise considered stable and protected, exhibit an elevated DNA 
mutation frequency compared with nonquiescent cells (Fig. 2 E). 
Our data suggest that DNA damage and mutations including 
GCRs occur mostly in old cells and are associated with a shorter 
life span, but do not provide conclusive evidence for the role 
of DNA damage as a major factor in the aging process (Vijg, 
2008). Sch9 appears to be responsible for the major portion of age-
dependent increase in DNA mutations because cells lacking 
SCH9 displayed reduced point mutations, small insertions/
deletions, and GCRs, whereas cells overexpressing SCH9, which 
models mammalian Akt-activating oncogene mutations (PTEN 
etc), displayed a significant increase in mutations. The effect of 
Sch9 on age-dependent mutations did not appear to be simply 
due to its effect on survival because, at a comparable percent of 
survival, the cumulative frequency of mutations in sch9 was 
less than half of that in wild-type cells (Fig. 1 C).
We observed a higher occurrence of multiple mutations 
within a short stretch of DNA in Can
r mutants from 7-d-old 
wild-type cultures than in sch9 mutants (Table I). This muta-
tion profile was reminiscent of that caused by the error-prone 
PolIV and PolV polymerases, which are involved in increased 
Rev1–Pol complex in age-related mutagenesis (Figs. 4 and 5), 
and the protection against oxidative damage to DNA exerted 
by deficiency in SCH9 (Fig. 6), we studied the role of super-
oxide and oxidative DNA damage in Sch9- and age-dependent 
genomic instability.
The life span extension associated with deficiencies in 
Sch9 and Ras2/cAMP/PKA requires the expression of the mito-
chondrial superoxide dismutase (MnSOD; Fabrizio et al., 2003) 
and of the stress response transcription factors Msn2/4 and Gis1 
(Pedruzzi et al., 2000; Wei et al., 2008). Both the stress response 
element (STRE) and post-diauxic shift motif (PDS) are present 
in the promoter region of SOD2, which is up-regulated in cells 
lacking Sch9 (Fig. S2 A). The genome-wide expression pro-
filing also indicated that deletion of SCH9 causes a metabolic 
switch from the TCA cycle and respiration to glycolysis and 
glycerol biosynthesis, as well as a general reduction of mRNA 
levels of proteins targeted to mitochondria (Wei et al., 2009), 
which is in agreement with the reduced generation and/or level 
of superoxide in sch9 mutants.
Overexpression of the cytosolic Cu, Zn superoxide dis-
mutase SOD1 (introduction of plasmid YEp352-SOD1ox[URA3] 
induced an eightfold increase of SOD1 mRNA level compared 
with the wild type; Figs. S2 B and S3), was able to completely 
abolish the detrimental effect of the overexpression of SCH9 on 
either age-dependent spontaneous or paraquat-induced genomic 
instability (Fig. 7, A and B). Moreover, the overexpression   
of either SOD1 or SOD2 (introduction of plasmid YEp351-
SOD2ox[LEU2] induced a fourfold increase of the SOD2 mRNA 
level compared with the wild type; Figs. S2 B and S3) was effec-
tive in attenuating age-dependent mutation frequency increase in 
Gis1-deficient cells and down-regulating the REV1 mRNA level 
(Fig. 8, A–C). To test whether the combination of both a high 
superoxide and REV1 level contribute to age-dependent muta-
tions, we treated rev1 mutants and REV1 overexpressors with 
1 mM paraquat (Fig. 9, A–C). REV1 overexpression did not in-
crease further paraquat-dependent mutagenesis, possibly because 
the  superoxide  generated  by  paraquat  might  have  maximized 
REV1 expression (Fig. 9 C). SOD1 and SOD2 overexpression did 
cause a significant decrease in the REV1 mRNA level (Fig. 9 D). 
These results indicate that the Sch9-dependent accumulation of 
oxidative DNA damage is the major source of age-dependent 
genomic instability in nondividing cells. We propose that during 
the first round of replication, the Rev1–Pol complex processes 
the oxidation-induced abasic sites and generates base substitu-
tions to avoid GCRs and possibly cell death (Fig. 9 E).
Figure  7.  SOD1  overexpression  attenuates 
age-dependent  oxidative  stress  and  SCH9 
overexpression–induced  genomic  instability. 
(A) Mutation frequency (Can
r) of cells during 
normal chronological aging. (B) Mutation fre-
quency (Can
r) of cells treated with 1 mM para-
quat on day 1 and on day 3. Strains shown 
are wild type (WT; DBY476), sch9, and cell 
overexpression of SOD1 and/or SCH9. *, P < 
0.05; mutant versus WT. ^, P < 0.01; mutant 
versus sch9, two-tailed t test at the indicated 
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mRNA level than the 60% measured in Sch9-deficient cells if 
its regulation was only dependent on the cell cycle. These re-
sults indicate additional regulation/activation of REV1 expres-
sion in aging cells.
rev1 mutants showed an 80% decrease in mutation fre-
quency compared with wild-type cells (Fig. 4 C). Rev1 is known 
to insert C opposite the abasic site (Nelson et al., 1996), but it 
has also been shown to insert all four nucleotides to repair a gap 
(Haracska et al., 2002). This mutagenic role of Rev1 has been 
confirmed in vivo (Auerbach et al., 2005). The base substitu-
tions observed in the CAN1 gene (Table I) were consistent with 
the deoxycytidine monophosphate transferase activity of Rev1 
or its modulation of thymidine monophosphate insertions oppo-
site an abasic site, although part of them are likely to be generated 
independently of TLS. Furthermore, Rev1 can play a structural 
role in aiding polymerases bypass lesion sites, which does not 
depend on its nucleotidyl transferase activity (Nelson et al., 2000; 
Lawrence, 2004). In this case, the insertion of the nucleotide 
opposite an abasic site is catalyzed by polymerase  (Haracska 
et al., 2001).
The deletion of REV1 in wild-type cells blocked the gen-
eration of multiple mutations/insertions/deletions within a short 
stretch of DNA sequence (Table I). Previous studies from the 
laboratories of S. Jinks-Robertson and T.A. Kunkel (Kozmin et al., 
2003; Minesinger et al., 2006) described spontaneous “complex” 
mutability in nondividing E. coli (McKenzie et al., 2001; 
Kobayashi et al., 2002), and of that caused by eukaryotic TLS 
polymerases (Rev1, Pol, and Rad30; Waters et al., 2009). In 
the sch9 mutants, base substitutions were mostly C → A, fol-
lowed in one case only by a T insertion (Table I), suggesting 
that the lack of SCH9 not only reduced the frequency of sponta-
neous age-dependent mutations but also prevented multiple 
mutations within a short stretch of DNA sequence.
REV1 was among the most down-regulated DNA repair-
related genes in the sch9 mutant, and its expression (mRNA 
level) was reduced 40% compared with the wild type on day 3 
(Figs. 3 C and 4 A). The lack of REV1 prevented the mutation 
frequency increase associated with aging or induced by SCH9 
overexpression, but did not affect the mutation frequency of 
sch9 (Fig. 4). Rev1 expression is threefold higher during 
G2/M than in G1 phase (Waters and Walker, 2006; Sabbioneda 
et al., 2007). Based on these results and on our FACS data (Fig.   
S1 A), we would have expected a smaller reduction of the REV1 
Figure 8.  Oxidative stress and genomic instability. (A and B) Overexpres-
sion of SOD1 or SOD2 extends life span and reduces genomic stability 
associated with gis1 mutants. *, P < 0.05; **, P < 0.01; compared with 
gis1, two-tailed t test at the indicated time points (n = 4). (C) mRNA levels 
of REV1 in wild-type (WT; DBY746), gis1, and gis1 cells overexpressing 
either SOD1 or SOD2. mRNA extracted from 3-d-old cells was subjected 
to quantitative real-time PCR analysis. **, P < 0.01; mutant versus WT (n = 
12, ANOVA test, Tukey’s test). Error bars indicate ±SEM.
Figure  9.  Rev1  mediates  oxidative  stress  induced  genomic  instability. 
(A–C) Mutation frequency (Can
r) of the wild type (DBY476), rev1, and 
cells overexpressing REV1 (REV1ox) during chronological aging and under 
oxidative stress (1 mM paraquat at day 1 and at day 3). *, P < 0.05;   
**, P < 0.01; rev1 versus wild-type (WT) untreated, two-tailed t test at the 
indicated time points (n = 4). Error bars indicate ±SEM. (D) REV1 mRNA 
levels at day 3. REV1 mRNA level were normalized to ACT1 and represent 
mean ± SEM (error bars) of the percentage of wild type. **, P < 0.01; 
compared with WT. ^^, P < 0.01; compared with sch9 (two-tailed t test, 
n = 8–12). (E) Modulation of oxidative stress and genomic instability by 
Sch9. During chronological aging, the oncogene homologue SCH9 inhib-
its the expression of genes involved in glycolysis and promotes respiration. 
Sch9 also regulates the error-prone Pol complex component Rev1 through 
the stress response transcription factor Gis1. Accumulation of oxidative 
DNA damage during aging activates Rev1-mediated TLS, which leads to 
increased base substitutions and reduced GCRs in the first round of DNA 
replication when cells exit the arrested state.JCB • VOLUME 186 • NUMBER 4 • 2009   520
IGF-I (Vergara et al., 2004) or Akt (Skeen et al., 2006), and the 
reduction in tumors in C. elegans deficient in the IGF-I–like re-
ceptor DAF-2 (Pinkston et al., 2006) are consistent with our 
previous and present results indicating a link between these onco-
genes, mutagenesis, and cancer (Longo et al., 2008). It will be 
important to determine whether these conserved antiaging path-
ways may regulate, in addition to cell growth and apoptosis, oxi-
dation damage of DNA and error-prone DNA repair proteins in 
both dividing and nondividing cells.
Materials and methods
Yeast strains
The experiments were performed in DBY746 (MAT,leu2-3,112,his31,trp1-
289,ura3-52,GAL
+), provided by D. Botstein, Massachusetts Institute of 
Technology, Cambridge, MA. The strain BY4741 (MATa,his31leu20,
met150,ura30; Thermo Fisher Scientific) was used to confirm the results 
obtained with the DBY746 strain.
Strain  EH150  (MATa,lys2BglII,trp1-,his3-200,ura3-52,ade2-1o) 
was used for the small insertion/deletion mutation assay (provided by 
E. Heidenreich, Institute of Cancer Research, Medical University of Vienna, 
Vienna, Austria). The sch9 mutant has been described previously (Fabrizio 
et al., 2001). All the mutant strains were originated in the different back-
grounds by one-step gene replacement according to Brachmann et al. (1998). 
K.A. Morano (University of Texas Medical School, Houston, TX) provided low 
copy plasmid pRS416-HA3-SCH9. Multicopy 2  plasmid carrying REV1 was 
obtained from Thermo Fisher Scientific. Overexpressor plasmids for SOD2 
and SOD1 were constructed in multicopy vectors (YEp352 and YEp351, 
respectively) and have been described previously (Fabrizio et al., 2003).
Growth conditions
Yeast chronological life span was monitored in expired SDC medium by 
measuring colony-forming units (CFUs) every 48 h. The number of CFUs at 
day 1 was considered to be the initial survival (100%) and was used to deter-
mine the age-dependent mortality (Fabrizio and Longo, 2003).
Can1 mutation frequency measurements
Spontaneous mutation frequency was evaluated by measuring the frequency 
of mutations of the CAN1 (YEL063) gene. In brief, overnight inoculations 
were diluted in liquid SDC medium and incubated at 30°C. The cells’ viabil-
ity was measured every 2 d starting at day 1 by plating appropriate dilutions 
onto yeast extract peptone dextrose (YPD) medium plates and counting the 
CFUs. To identify the canavanine-resistant mutants (Can
r) in the liquid culture, 
an appropriate number of cells (starting amount of 2 × 10
7 cells) was 
harvested by centrifugation, washed once with sterile water, and plated on 
selective medium (SDC-Arg supplemented with 60 µg/ml  l-canavanine 
sulfate). Mutant colonies were counted after 3–4 d. The mutation frequency 
was expressed as the ratio of Can
r to total viable cells.
Large-scale measurement of GCRs
To detect GCRs, a DBY476 background strain was generated by the re-
placement of HXT13 (YEL069), encoding for a highly redundant hexose 
transporter, with a URA3 cassette (Chen and Kolodner, 1999). HXT13 is 
located 7.5 kb telomeric to CAN1 on chromosome V. The experiment was 
conducted similarly to that described for the Can1 mutations, but the 
detection for the loss of both CAN1 and URA3 was performed on SDC-Arg 
plates containing 1 mg/ml 5-fluoroorotic acid (5FOA) and 60 µg/ml 
l-canavanine. Mutant colonies were counted after 3–4 d.
Measurement of age-dependent small insertion/deletion mutations
Based on the experimental design proposed by Heidenreich et al., (2003) 
and Heidenreich and Wintersberger (1998), we generated sch9 mutants 
in a Lys
 strain (EH150) in which a lys2BglII mutation was constructed by 
filling in a BglII restriction site of the LYS2 gene. The resulting +4 shift in the 
open reading frame causes an auxotrophy for lysine that can be reversed 
by small age-dependent insertion/deletion mutations. Cells were plated 
onto selective SDC-Lys medium. The experiments were performed similarly 
to the one described for the Can1 mutations.
Measurement of age-dependent single-base substitution mutations
To monitor the frequency of reversion of a base substitution, we used the 
strain DBY746 that carries a trp 1–289 amber mutation (C → T at residue 
mutational events, in which a frameshift is accompanied by one 
or more base substitutions. These events depended on the muta-
genic TLS polymerase Pol activity, which functions in associa-
tion with Rev1 (Minesinger et al., 2006). Our results show that 
age-dependent mutagenesis was reduced in cells lacking either 
REV3 or REV7, the two subunits of Pol polymerase, but was 
increased in mutants lacking RAD30, which is regarded as an 
error-free DNA damage bypass enzyme (Johnson et al., 1999; 
Washington et al., 1999; Prakash et al., 2000).
These findings support the hypothesis that the majority of 
age-dependent mutations are generated through the activity of 
the Rev1–Pol error-prone complex, whose activity may be 
elevated in aging cells (Fig. 5 E). The down-regulation of Rev1 
expression alone, however, may not explain the complete absence 
of TLS activity in sch9 mutants. Rev1 is not absolutely required 
for TLS in yeast (Pagès et al., 2008); we cannot exclude the pos-
sibility that the deficiency and/or modification in other impor-
tant TLS components, such as proliferating cell nuclear antigen 
ubiquitination and/or Pol itself, contributed to the complete 
absence of TLS in sch9 mutant cells (Fig. 5 E).
Mutants lacking SCH9 were highly protected against ex-
ogenous oxidative stress (Fabrizio et al., 2001). This study shows 
that the deficiency in SCH9 protected against endogenous age-
dependent oxidative damage to DNA, as indicated by the level of 
8-OHdG (Fig. 6 C). The elevated expression of SOD2 and pro-
tection of the DNA against oxidative damage in sch9 mutants, 
together with the effect of the overexpression of both SOD1 and 
SOD2 in reducing point mutations, indicate that Sch9 promotes 
mutations by a superoxide-dependent mechanism. We propose 
that superoxide and the oxidized DNA cause an increased ex-
pression of REV1 and activation of the error-prone Pol, which 
result in point mutations during the first round of replication in 
order to prevent double strand breaks and GCRs (Fig. 9 E).
Although the deletion of SCH9 causes Gis1-dependent re-
pression of REV1 expression (Fig. 4 A), Sch9 and Gis1 may not 
necessarily function in the same pathway as Rev1/Pol. The super-
oxide production and DNA oxidation regulated by Sch9 may 
instead directly lead to the activation of the error-prone system 
(Brunet et al., 2004; Shen et al., 2007). In fact, the overexpres-
sion of either SOD1 or SOD2 was sufficient to decrease REV1 
expression (Fig. 9 D).
Recent work in neurons and mice suggests that somatic 
mutations associated with Huntington’s disease occur during 
the removal of oxidation lesions by an error-prone mechanism 
dependent on the base excision repair enzyme Ogg1 (Kovtun 
et al., 2007). Our data raise the possibility that down-regulation 
of the mammalian Akt/S6K signaling pathway implicated in life 
span regulation may also regulate oxidative damage as well as 
error-prone polymerases that can cause DNA damage and dis-
eases during aging. Notably, down-regulation of Rev1 in human 
cells  reduced  UV-dependent  mutations  (Gibbs  et  al.,  2000), 
which suggests that the role of this protein is at least partially 
conserved from yeast to humans. The connection between 
oncogene homologs, Rev1, and age-dependent genomic insta-
bility observed in the simple S. cerevisiae model has not been 
demonstrated in mammals. However, the recent papers showing 
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housekeeping  gene  ACT1  were  5-AGCTCCAATGAACCCTAAATCA-3 
and 5-ACGACGTGAGTAACACCATCAC-3, respectively. The concentra-
tion (ng/µl) of both genes was calculated by reference to the respective 
standard curve. Relative gene expression was expressed as a ratio of REV1 
gene concentration to ACT1 concentration, and the values given represent 
the percentage of wild type of the mean gene expression ± SEM.
TLS in yeast cell-free nuclear extracts
Yeast cell-free nuclear extracts were prepared according to the established pro-
tocol (Wang, 2006). In brief, yeast cells from indicated strains (wild type or 
sch9) were grown at 30°C in SDC medium until day 3. Cells were harvested 
by centrifugation for 10 min, washed in water, and suspended at 0.1 g/ml in 
0.1M EDTA, pH 8.0/10 mM dithiothreitol buffer. After a 30-min incubation, 
cells were pelleted and suspended at 1 g/ml in 1 M sorbitol solution, and yeast 
lytic enzyme (Zymo Research Corporation) was added at 1.4–2.8 mg/g of 
cells. Spheroplasts were resuspended in Ficoll buffer and lysed with a Teflon 
glass homogenizer. Nuclei were recovered from the supernatant by at least 
four consecutive centrifugations and resuspended in lysis buffer. After precipita-
tion with ammonium sulfate, proteins were dialyzed in Hepes buffer. Precipi-
tates formed during dialysis were removed by centrifugation, and the resulting 
nuclear extracts were stored at 70°C. Extract concentration was quantified 
using a Pierce BCA protein assay (Thermo Fisher Scientific).
48-mer undamaged or damaged oligonucleotide substrate (48 mer)   
5-TCGATACTGGTACTAATGATTAACGACTXAAGCACGTCCGTACCA-
TCG-3 (X is either T for the undamaged or tetrahydrofurane-type of abasic 
site for the damaged template) and a 12-mer primer 5-CGATGGTACGGA-3 
were synthesized on a 3400 DNA Synthesizer (Applied Biosystems) and 
purified by denaturing PAGE. TLS reactions (50 µl volume) were performed 
in a TLS buffer (20 mM Hepes, pH 7.8, 7 mM MgCl2, 1 mM DTT, and   
25 mM NaCl) containing 200 µM deoxynucleotide triphosphate, 100 nM 
of 
32P-labeled primer annealed to the template (undamaged or damaged), 
and the indicated amount of wild-type or sch9 nuclear extract (0, 5, 10, or 
20 µg). After incubation at 30°C for 30 min, reactions were terminated by 
addition of 10 mM EDTA and 0.4 mg/ml proteinase K, and incubated for an 
additional 30 min at 37°C. TLS reaction products were purified by extracting 
twice with phenol:chloroform:isoamyl alcohol, separated on a 19% denatur-
ing PAGE. Gel band intensities were measured by phosphorimaging with 
ImageQuant software (GE Healthcare).
Statistical analysis
Longevity curves and mutation frequency curves were analyzed by an un-
paired two-tailed t test (P-values were P < 0.001, P < 0.01, and P < 0.05) 
on the data for each pair of strains at each day. RT-PCR data were ana-
lyzed by a one-way analysis of variance (ANOVA) test.
Online supplemental material
Fig. S1 shows the percentage distribution in each cell cycle compartment, 
as resulted from the FACS analysis from wild-type and SCH9-deficient cul-
tures at early time points, and the cell cycle profiles of quiescent and non-
quiescent fractions from wild-type and SCH9-deficient cultures after density 
gradient separation. Fig. S2 shows the mRNA SODs and REV1 levels in   
3-d-old wild-type, sch9, gis1, and gis1sch9 mutants and in cells 
overexpressing SCH9 and mRNA SODs and REV1 levels in 3-d-old wild-
type and sch9 mutants cells treated with 1 mM paraquat for 48 h. Fig. S3 
shows the survival and age-dependent mutation frequency of plasmid vec-
tors. Table S1 shows the percentage of early regrowth in wild-type and Sch9-
deficient cells. Table S2 shows the microarray gene expression analysis of 
DNA repair genes in sch9 cells. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200906011/DC1.
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